Evidence map›Paper›PMID 26971870›Full record

ArticleCell chemical biology2016

Monstrous Mycobacterial Lipids.

Jessica Seeliger, D Branch Moody

Open access · bronzeAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jessica SeeligerDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11790, USA.
D Branch MoodyDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: bmoody@partners.org.
Brigham and Women's Hospital · USStony Brook University · US

Funding

Metabolomics Core U19AI111224 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH, MURRAY, MEGAN B · 2015 to 2021
$20.4M
Role of Tuberculosinyl Metabolites in M. Tuberculosis VirulenceR01AI116604 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2015 to 2019
$2.4M
Group 1 CD1-restricted Autoreactive T cells in Inflammatory DiseaseR21AI117238 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WANG, CHYUNG-RU · 2015 to 2016
$411k
Inducible Gene Regulation in MycobacteriaR21AI103321 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI SEELIGER, JESSICA CHUANG · 2013 to 2014
$391k
Functional analysis of human NKT cells and myeloid DCs within murine SCID hostsR21AI076707 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GUMPERZ, JENNY E. · 2009 to 2010
$371k
NIAID NIH HHS 1R21AI103321NIAID NIH HHS R01 AI116604NIAID NIH HHS R21 AI103321NIAID NIH HHS R21 AI117238NIAID NIH HHS U19 AI111224PHS HHS R01 116604PHS HHS U19 111224
6 · The paper itself

Abstract

When it comes to lipid diversity, no bacterial genus approaches Mycobacterium. In this issue of Cell Chemical Biology, Burbaud et al. (2016) provide a multi-genic working model for the biosynthesis of trehalose polyphleate (TPP), one of the largest known lipids in mycobacteria. They demonstrate that this lipid is made by diverse mycobacterial species, including those of medical importance.

Indexed as

MycobacteriumLipidsMembrane LipidsMycobacterium bovisMycobacterium InfectionsMycobacterium tuberculosisTrehaloseLipidsMembrane LipidsTrehalose

Identifiers

PMID26971870
PMCPMC6309405
OpenAlexW2275517129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.